Automated Microbiology Market Size, Share, and Trends 2024 to 2034

The global automated microbiology market size is calculated at USD 8.80 billion in 2025 and is forecasted to reach around USD 22.03 billion by 2034, accelerating at a CAGR of 10.73% from 2025 to 2034. The North America market size surpassed USD 3.26 billion in 2024 and is expanding at a CAGR of 10.92% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.

  • Last Updated : March 2025
  • Report Code : 5722
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Automated Microbiology Market 

5.1. COVID-19 Landscape: Automated Microbiology Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Automated Microbiology Market, By Product

8.1. Automated Microbiology Market, by Product

8.1.1. Instruments

8.1.1.1. Market Revenue and Forecast

8.1.2. Automated Microbial Identification Systems

8.1.2.1. Market Revenue and Forecast

8.1.3. Automated Blood Culture Systems

8.1.3.1. Market Revenue and Forecast

8.1.4. Automated Colony Counters Automated Sample Preparation Systems

8.1.4.1. Market Revenue and Forecast

8.1.5. Automated Sample Preparation Systems

8.1.5.1. Market Revenue and Forecast

8.1.6. Automated Antibiotic Susceptibility Testing (AST) Systems

8.1.6.1. Market Revenue and Forecast

8.1.7. Other Instruments

8.1.7.1. Market Revenue and Forecast

8.1.8. Reagents and Kits

8.1.8.1. Market Revenue and Forecast

8.1.9. Culture Media

8.1.9.1. Market Revenue and Forecast

8.1.10. Stains and Dyes

8.1.10.1. Market Revenue and Forecast

8.1.11. Assay Kits and Panels

8.1.11.1. Market Revenue and Forecast

8.1.12. Others

8.1.12.1. Market Revenue and Forecast

8.1.13. Software

8.1.13.1. Market Revenue and Forecast

Chapter 9. Global Automated Microbiology Market, By Automation Type

9.1. Automated Microbiology Market, by Automation Type

9.1.1. Fully Automated

9.1.1.1. Market Revenue and Forecast

9.1.2. Semi-Automated

9.1.2.1. Market Revenue and Forecast

 Chapter 10. Global Automated Microbiology Market, By Application 

10.1. Automated Microbiology Market, by Application

10.1.1. Biopharmaceutical Production

10.1.1.1. Market Revenue and Forecast

10.1.2. Clinical Diagnostics

10.1.2.1. Market Revenue and Forecast

10.1.3. Environmental and Water Testing

10.1.3.1. Market Revenue and Forecast

10.1.4. Food and Beverage Testing

10.1.4.1. Market Revenue and Forecast

10.1.5. Other Application

10.1.5.1. Market Revenue and Forecast

Chapter 11. Global Automated Microbiology Market, By End-use 

11.1. Automated Microbiology Market, by End-use

11.1.1. Pharmaceutical and Biotechnology Companies

11.1.1.1. Market Revenue and Forecast

11.1.2. Hospitals and Diagnostic Laboratories

11.1.2.1. Market Revenue and Forecast

11.1.3. Academic and Research Institutes

11.1.3.1. Market Revenue and Forecast

11.1.4. Other End Use

11.1.4.1. Market Revenue and Forecast

Chapter 12. Global Automated Microbiology Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Product

12.1.2. Market Revenue and Forecast, by Automation Type

12.1.3. Market Revenue and Forecast, by Application

12.1.4. Market Revenue and Forecast, by End-use

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Product

12.1.5.2. Market Revenue and Forecast, by Automation Type

12.1.5.3. Market Revenue and Forecast, by Application

12.1.5.4. Market Revenue and Forecast, by End-use

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Product

12.1.6.2. Market Revenue and Forecast, by Automation Type

12.1.6.3. Market Revenue and Forecast, by Application

12.1.6.4. Market Revenue and Forecast, by End-use

12.2. Europe

12.2.1. Market Revenue and Forecast, by Product

12.2.2. Market Revenue and Forecast, by Automation Type

12.2.3. Market Revenue and Forecast, by Application

12.2.4. Market Revenue and Forecast, by End-use

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Product

12.2.5.2. Market Revenue and Forecast, by Automation Type

12.2.5.3. Market Revenue and Forecast, by Application

12.2.5.4. Market Revenue and Forecast, by End-use

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Product

12.2.6.2. Market Revenue and Forecast, by Automation Type

12.2.6.3. Market Revenue and Forecast, by Application

12.2.6.4. Market Revenue and Forecast, by End-use

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Product

12.2.7.2. Market Revenue and Forecast, by Automation Type

12.2.7.3. Market Revenue and Forecast, by Application

12.2.7.4. Market Revenue and Forecast, by End-use

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Product

12.2.8.2. Market Revenue and Forecast, by Automation Type

12.2.8.3. Market Revenue and Forecast, by Application

12.2.8.4. Market Revenue and Forecast, by End-use

12.3. APAC

12.3.1. Market Revenue and Forecast, by Product

12.3.2. Market Revenue and Forecast, by Automation Type

12.3.3. Market Revenue and Forecast, by Application

12.3.4. Market Revenue and Forecast, by End-use

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Product

12.3.5.2. Market Revenue and Forecast, by Automation Type

12.3.5.3. Market Revenue and Forecast, by Application

12.3.5.4. Market Revenue and Forecast, by End-use

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Product

12.3.6.2. Market Revenue and Forecast, by Automation Type

12.3.6.3. Market Revenue and Forecast, by Application

12.3.6.4. Market Revenue and Forecast, by End-use

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Product

12.3.7.2. Market Revenue and Forecast, by Automation Type

12.3.7.3. Market Revenue and Forecast, by Application

12.3.7.4. Market Revenue and Forecast, by End-use

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Product

12.3.8.2. Market Revenue and Forecast, by Automation Type

12.3.8.3. Market Revenue and Forecast, by Application

12.3.8.4. Market Revenue and Forecast, by End-use

12.4. MEA

12.4.1. Market Revenue and Forecast, by Product

12.4.2. Market Revenue and Forecast, by Automation Type

12.4.3. Market Revenue and Forecast, by Application

12.4.4. Market Revenue and Forecast, by End-use

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Product

12.4.5.2. Market Revenue and Forecast, by Automation Type

12.4.5.3. Market Revenue and Forecast, by Application

12.4.5.4. Market Revenue and Forecast, by End-use

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Product

12.4.6.2. Market Revenue and Forecast, by Automation Type

12.4.6.3. Market Revenue and Forecast, by Application

12.4.6.4. Market Revenue and Forecast, by End-use

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Product

12.4.7.2. Market Revenue and Forecast, by Automation Type

12.4.7.3. Market Revenue and Forecast, by Application

12.4.7.4. Market Revenue and Forecast, by End-use

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Product

12.4.8.2. Market Revenue and Forecast, by Automation Type

12.4.8.3. Market Revenue and Forecast, by Application

12.4.8.4. Market Revenue and Forecast, by End-use

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Product

12.5.2. Market Revenue and Forecast, by Automation Type

12.5.3. Market Revenue and Forecast, by Application

12.5.4. Market Revenue and Forecast, by End-use

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Product

12.5.5.2. Market Revenue and Forecast, by Automation Type

12.5.5.3. Market Revenue and Forecast, by Application

12.5.5.4. Market Revenue and Forecast, by End-use

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Product

12.5.6.2. Market Revenue and Forecast, by Automation Type

12.5.6.3. Market Revenue and Forecast, by Application

12.5.6.4. Market Revenue and Forecast, by End-use

Chapter 13. Company Profiles

13.1. BD

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. QIAGEN

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Thermo Fisher Scientific In.

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Agilent Technologies, Inc.

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Danaher

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Merck KGaA

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. bioMérieux

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. DiaSorin S.p.A.

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. BioRad Laboratories, Inc.

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global automated microbiology market size is expected to grow from USD 7.95 billion in 2024 to USD 22.03 billion by 2034.

The automated microbiology market is anticipated to grow at a CAGR of 10.73% between 2025 and 2034.

The major players operating in the automated microbiology market are BD, QIAGEN, Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Danaher, Merck KGaA, bioMérieux, Abbott, DiaSorin S.p.A., BioRad Laboratories, Inc., and Others

The driving factors of the automated microbiology market are the incidence of infectious diseases across the globe.

North America region will lead the global automated microbiology market during the forecast period 2025 to 2034.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client